Development of main disturbances of hemostasis in patients with obesity

Kardiologiya

Volumn 52, Issue 2, 2012, Pages 59-64

  Shishkova, V N ^a   Remennik, A Yu ^a   Zotova, L I ^a  

^a NONE

Author keywords

Hemostasis; Metabolic syndrome; Obesity

Indexed keywords

BLOOD CLOTTING FACTOR;

ADULT; ARTICLE; BLOOD; BLOOD CLOTTING; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASE; DYSLIPIDEMIA; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; OBESITY; RISK FACTOR; WAIST CIRCUMFERENCE;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CARBOHYDRATE METABOLISM; CARDIOVASCULAR DISEASES; DYSLIPIDEMIAS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84866757761     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Haslam D. W. Obesity. Lancet 2005;366:1197-1209.
2. Stem M., Fatehi P., Williams K. et al. Predicting future cardiovascular disease. Diabetes Care 2002;25:1851-1856.
3. Calk E.E., Thun M.J., PetrelliJ.M. et al. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097-1115.
4. Wild S., Roglic G. et al. Global Prevalence of Diabetes. Estimates for the year 2000 and projections for 2030 Diabetes Care 2004;27:1047-1053.
5. Reaven G.M. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
6. Connolly S.J., Ezekowltz M.D., Yusuf S. et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-1151.
7. Bucciarelli P., Mannucci P.M. The hemostatic system through aging and menopause. Climacteric 2009;12 Suppl 1:47-51.
8. Lobo R.A. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10-18.
9. Avellone G., Di Garbo V., Cordova R. at al. Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution. Thromb Res 1994;75:223-231.
10. De Pergola G., De Mitrio V., Giorgino F. et al. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distriction. Int J Obes Relat Metab Disord 1997;21:527-535.
11. Peverill R.E., Teede H.J., Malan E. Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women. Clin Sci (Lond) 2007;113:383-391.
12. Scarabin P.Y., Ylssoc A.M., Kirzin J.M. et al. Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII. Arterioscler Thromb Vase Biol 1996;16:1170-1176.
13. Devaraj S., Rosenson R.S., Jialal I. Metabolic syndrome: an appraisal of the proinflammatory and procoagulant status. Endocrinol Metab Clin North Am 2004;33:31-453.
14. Sakkinen PA., Wahl P., Cushmann M. et al. Clustering of pro-coagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome. Am J Epidemiol 2000;152:897-907.
15. Ay C, Tengler T., Vormittag R. et al. Venous thromboembolism - a manifestation of the metabolic syndrome. Haematologica 2007;92:374-380.
16. Ragab A., Abousamra N.K., Higazy A. et al. Relationship between insulin resistance and some coagulation and fibrinolytic parameters it patients with metabolic syndrome. Lab Hematol 2008;14:1-6.
17. Wannamethee S.G., Lowe G.D., ShaperA.G. et al. The metabolic syndrome and insulin resistance: relationship to haemostatic and inflammatory markers in older non-disbetic men. Atherosclerosis 2005;181:101-108.
18. Kahn S.E., Zinman B., Haffher S.M. et al. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 2006;55:2357-2364.
19. Nieuwdorp M., Stroes E.S., Meijers J. C Hypercoagulability in the metabolic syndrome. Curr Opin Pharmacol 2005;5:155-159.
20. Polac I., Stachowtak G., Jedrzejczyk S. Assessment of fat tissue distribution impact on selected prothrombin and fibrinolytic factors in pre- and postmenopausal women. Ginekol Pol 2000;71:1083-1088.
21. AgewallS., Bokemark L. Wikstrand J. etai. Insulin sensitivy and hemostatic factors in clinically healthy 58-year-old men. Thromb Haemost 2000;84:571-575.
22. Sola E., Vaya A., Villa P. et al. Obesity and activated protein C resistance. Pathophysiol. Haemost Thromb 2008;36:64-68.
23. Swiatkowska-Stodulska R., Skibowska-Bielinska A., Bakowska A. et al. Assessment of selected haemostatic parameters in obese patients. Endokrynol Pol 2007;58:505-509.